Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark D Minden

Showing results (141-150 of 308) with videos related to

Pageof 31
Sort By:
Leukemia|August 23, 2019
Cryptic genomic lesions in adverse-risk acute myeloid leukemia identified by integrated whole genome and transcriptome sequencingJaeseung C Kim, Philip C Zuzarte, Tracy Murphy, et al.
Leukemia & Lymphoma|June 10, 2017
Remissions after third induction chemotherapy for primary non-responders with acute myeloid leukemia (AML) are uncommon and short-livedSara Farshchi Zarabi, Steven Chan, Vikas Gupta, et al.
European Journal of Haematology|August 8, 2024
Evolution from an antecedent chronic myeloid malignancy does not impact survival outcomes in NPM1-mutated AMLElliot Smith, Eshetu G Atenafu, Aniket Bankar, et al.
Blood Advances|November 4, 2020
CD200 expression marks leukemia stem cells in human AMLJenny M Ho, Stephanie M Dobson, Veronique Voisin, et al.
Cancer|February 21, 2008
Outcome of patients who develop acute leukemia or myelodysplasia as a second malignancy after solid tumors treated surgically or with strategies that include chemotherapy and/or radiationArwa Abdelhameed, Gregory R Pond, Nicholas Mitsakakis, et al.
Experimental Hematology|December 10, 2023
Epigenetic vulnerabilities of leukemia harboring inactivating EZH2 mutationsMona A Alqazzaz, Genna M Luciani, Victoria Vu, et al.
Proteomics|February 9, 2017
Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome, and tyrosine-phosphatome in acute myeloid leukemiaJiefei Tong, Mohamed Helmy, Florence M G Cavalli, et al.
Ejhaem|July 18, 2022
Single cell proteogenomic sequencing identifies a relapse-fated AML subclone carrying <i>FLT3</i>-ITD with CN-LOH at chr13qTaeHyung Kim, Hyewon Lee, Jose-Mario Capo-Chichi, et al.
Blood|January 31, 2013
Treatment outcomes following leukemic transformation in Philadelphia-negative myeloproliferative neoplasmsJames A Kennedy, Eshetu G Atenafu, Hans A Messner, et al.
Molecular and Cellular Biology|April 30, 2014
The Pim-1 protein kinase is an important regulator of MET receptor tyrosine kinase levels and signalingBo Cen, Ying Xiong, Jin H Song, et al.
Pageof 31

Showing results (141-150 of 308) with videos related to

Sort By:
Pageof 31
Leukemia|August 23, 2019
Cryptic genomic lesions in adverse-risk acute myeloid leukemia identified by integrated whole genome and transcriptome sequencingJaeseung C Kim, Philip C Zuzarte, Tracy Murphy, et al.
Leukemia & Lymphoma|June 10, 2017
Remissions after third induction chemotherapy for primary non-responders with acute myeloid leukemia (AML) are uncommon and short-livedSara Farshchi Zarabi, Steven Chan, Vikas Gupta, et al.
European Journal of Haematology|August 8, 2024
Evolution from an antecedent chronic myeloid malignancy does not impact survival outcomes in NPM1-mutated AMLElliot Smith, Eshetu G Atenafu, Aniket Bankar, et al.
Blood Advances|November 4, 2020
CD200 expression marks leukemia stem cells in human AMLJenny M Ho, Stephanie M Dobson, Veronique Voisin, et al.
Cancer|February 21, 2008
Outcome of patients who develop acute leukemia or myelodysplasia as a second malignancy after solid tumors treated surgically or with strategies that include chemotherapy and/or radiationArwa Abdelhameed, Gregory R Pond, Nicholas Mitsakakis, et al.
Experimental Hematology|December 10, 2023
Epigenetic vulnerabilities of leukemia harboring inactivating EZH2 mutationsMona A Alqazzaz, Genna M Luciani, Victoria Vu, et al.
Proteomics|February 9, 2017
Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome, and tyrosine-phosphatome in acute myeloid leukemiaJiefei Tong, Mohamed Helmy, Florence M G Cavalli, et al.
Ejhaem|July 18, 2022
Single cell proteogenomic sequencing identifies a relapse-fated AML subclone carrying <i>FLT3</i>-ITD with CN-LOH at chr13qTaeHyung Kim, Hyewon Lee, Jose-Mario Capo-Chichi, et al.
Blood|January 31, 2013
Treatment outcomes following leukemic transformation in Philadelphia-negative myeloproliferative neoplasmsJames A Kennedy, Eshetu G Atenafu, Hans A Messner, et al.
Molecular and Cellular Biology|April 30, 2014
The Pim-1 protein kinase is an important regulator of MET receptor tyrosine kinase levels and signalingBo Cen, Ying Xiong, Jin H Song, et al.
Pageof 31